The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
about
Altered dietary salt intake for people with chronic kidney diseaseInterventions for promoting adherence to fluid intake and dietary salt restriction in people with end-stage kidney diseaseSodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.Techniques for the assessment of volume status in patients with end stage renal disease.Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients.Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.Target weight achievement and ultrafiltration rate thresholds: potential patient implicationsEducating end-stage renal disease patients on dialysis modality selection.A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers.Assessment and management of hypertension in patients on dialysis.Systolic blood pressure and mortality in patients on hemodialysis.Dietary sodium in chronic kidney disease: a comprehensive approachProbing dry-weight improves left ventricular mass indexDialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis.Comparison of hydration and nutritional status between young and elderly hemodialysis patients through bioimpedance analysis.Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study.Individualized reduction in dialysate sodium in conventional in-center hemodialysisThe relevance of dietary sodium in hemodialysis.Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patientsNutrition prescription to achieve positive outcomes in chronic kidney disease: a systematic review.Attending rounds: A patient with intradialytic hypotension.Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.Diastolic heart failure: a confusing concept.How is the heart best protected in chronic dialysis patients?: Control of extracellular volume.Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management.A brief review of intradialytic hypotension with a focus on survival.Ultrafiltration Rates and the Quality Incentive Program: Proposed Measure Definitions and Their Potential Dialysis Facility ImplicationsEffect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis.A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension.Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.Estimated dietary sodium intake in haemodialysis patients using food frequency questionnaires.Oxidative Stress in Hemodialysis Patients: A Review of the Literature.The effects of strict salt control on blood pressure and cardiac condition in end-stage renal disease: prospective-study.Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium.Ultrafiltration Rate Clinical Performance Measures: Ready for Primetime?Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis.Predialysis systolic blood pressure evolution in incident hemodialysis patients: effects of the dry weight method and prognostic value.Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers.
P2860
Q24188104-C4AD0507-0FB7-4442-9B80-07093744EC74Q24188174-ABE86CE4-753D-4117-9AF3-119D948724EDQ30235107-85962F2C-020E-407D-B7A3-0BB80E462551Q30248239-CC93ABD4-CF9F-4594-8B5A-5D5AFE02A49AQ30458665-23D7A1EA-7FFC-4D76-AA4C-3CB3E26086F5Q30841070-2319A3F8-0E48-4148-BD23-E0FCACA2FFB8Q30979522-2E436E39-6099-4CF7-BA1E-9395F5DC4838Q33759469-AA02D2E8-90FB-4EF4-BFF4-A31DD18C49B7Q33816963-7A535654-F18F-44F4-BD3F-6E9248EE4C5CQ33840387-06203E70-EA31-475F-BD79-8BBD89FC0F27Q33974561-759BC467-1652-49E1-94DD-0D3CE7685EAEQ34020784-11053D78-FDE1-42E5-88C6-6B39D2941569Q34063442-F07DDFFA-B548-4205-B290-B14319370A24Q34803893-25C046FB-3456-4AC5-B269-2EB571931E97Q35025436-F1411874-C613-4687-A76A-4E5E71FD34F3Q35769247-46CD5155-F9B2-4EA3-A63E-E091B1571787Q35970671-3B61E1D5-D75B-4B48-AFDA-85062925B466Q36190180-D9EB3C68-1B31-4E8D-9B41-A4DCD65A2F34Q36864772-B4958723-52B1-41DF-BB31-685DE433FF68Q37027090-215F5833-17A5-4752-96D9-38DBE929EEAAQ37189173-DEA4853E-EE10-46E9-87A7-82C7242084F3Q37564731-58296B2B-BF46-4B9D-9701-7E5AF73F56FBQ37682266-1A084848-CC78-402E-AAE1-CE431530A6FBQ37761241-B24EFC53-5ED9-45EB-93BF-7B6BD80C18B1Q38041989-A5A213FC-190C-45C9-8D3B-A11EE6EB21FDQ38179486-EB90D4EC-4012-4DE8-A100-9B1F664A944BQ38743790-737A06F6-0615-45BB-A142-991FBE7C3561Q39404701-05945DFF-2414-4E80-903C-729967952AAAQ39661518-33C50E20-A068-47DD-82DF-6CE126C724DCQ41022541-65C6CD08-E80A-4294-B96B-969B87F9DB7CQ41364143-808770C4-8B87-4520-9C76-98D757B9FEDFQ42025679-5EC2A5F0-F40A-43AF-8CA1-7BF8729C891EQ42253262-8FBD8377-15C9-4CB1-B4E7-8AE771E353B0Q43375953-8BDDE2B0-09ED-4973-A2FE-42BFCF0510CEQ44162241-469823B6-082B-4EA6-99A9-4990DA1C8C3BQ44645225-BFBD797F-2B86-4AAF-BF95-C9422139DAFCQ45421723-E73392B8-4771-4F12-AF00-8DC42164E1B1Q45967311-911FB18D-C9D7-4D4F-84AC-C3ED2C19ECA6Q47311087-AFD277D3-899F-47CB-9594-359940A9E782Q48179198-A3EDF95D-921F-4422-8BC1-7E47F30C2C32
P2860
The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The benefit of salt restrictio ...... enal disease by haemodialysis.
@en
The benefit of salt restrictio ...... enal disease by haemodialysis.
@nl
type
label
The benefit of salt restrictio ...... enal disease by haemodialysis.
@en
The benefit of salt restrictio ...... enal disease by haemodialysis.
@nl
prefLabel
The benefit of salt restrictio ...... enal disease by haemodialysis.
@en
The benefit of salt restrictio ...... enal disease by haemodialysis.
@nl
P2093
P356
P1476
The benefit of salt restrictio ...... renal disease by haemodialysis
@en
P2093
Levent H Can
Mehmet Ozkahya
Meral Kayikcioglu
Murat Tumuklu
Oner Ozdogan
Soner Duman
P304
P356
10.1093/NDT/GFN599
P407
P577
2008-11-11T00:00:00Z